BLUE JET HEALTHCARE
|
BLUE JET HEALTHCARE Last 5 Year Financial Ratios History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 17.59 | 9.44 | 9.23 | 10.47 | 1,428.73 |
| CEPS(Rs) | 18.62 | 11.06 | 10.67 | 11.75 | 9.30 |
| DPS(Rs) | 1.20 | 1.00 | - | - | - |
| Book NAV/Share(Rs) | 65.32 | 48.73 | 39.29 | 30.07 | 3,428.35 |
| Tax Rate(%) | 24.85 | 25.60 | 26.12 | 25.34 | 25.66 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 36.67 | 32.21 | 30.39 | 36.47 | 41.46 |
| EBIT Margin(%) | 39.44 | 30.95 | 30.23 | 36.07 | 39.24 |
| Pre Tax Margin(%) | 39.43 | 30.93 | 30.04 | 35.59 | 38.18 |
| PAT Margin (%) | 29.63 | 23.01 | 22.20 | 26.57 | 28.38 |
| Cash Profit Margin (%) | 31.36 | 26.96 | 25.67 | 29.81 | 32.32 |
| Performance Ratios | |||||
| ROA(%) | 21.22 | 14.75 | 17.74 | 26.11 | 23.87 |
| ROE(%) | 30.85 | 21.45 | 26.60 | 42.16 | 41.67 |
| ROCE(%) | 41.06 | 28.85 | 36.24 | 54.01 | 50.03 |
| Asset Turnover(x) | 0.72 | 0.64 | 0.80 | 0.98 | 0.84 |
| Sales/Fixed Asset(x) | 2.96 | 2.81 | 3.24 | 3.50 | 2.83 |
| Working Capital/Sales(x) | 1.37 | 1.42 | 1.47 | 1.83 | 2.20 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.34 | 0.36 | 0.31 | 0.29 | 0.35 |
| Receivable days | 93.28 | 106.77 | 118.17 | 99.18 | 105.35 |
| Inventory Days | 69.77 | 65.53 | 58.39 | 59.48 | 86.12 |
| Payable days | 47.23 | 48.81 | 59.93 | 73.70 | 128.23 |
| Valuation Parameters | |||||
| PER(x) | 50.06 | 40.51 | - | - | - |
| PCE(x) | 47.30 | 34.58 | - | - | - |
| Price/Book(x) | 13.48 | 7.85 | - | - | - |
| Yield(%) | 0.14 | 0.26 | - | - | - |
| EV/Net Sales(x) | 14.72 | 9.20 | -0.04 | -0.08 | -0.02 |
| EV/Core EBITDA(x) | 35.75 | 25.38 | -0.13 | -0.20 | -0.04 |
| EV/EBIT(x) | 37.32 | 29.74 | -0.14 | -0.21 | -0.05 |
| EV/CE(x) | 13.38 | 7.75 | -0.05 | -0.10 | -0.02 |
| M Cap / Sales | 14.83 | 9.32 | - | - | - |
| Growth Ratio | |||||
| Net Sales Growth(%) | 44.74 | -1.30 | 5.49 | 36.99 | - |
| Core EBITDA Growth(%) | 64.28 | 6.19 | -9.54 | 24.70 | - |
| EBIT Growth(%) | 84.42 | 1.05 | -11.58 | 25.91 | - |
| PAT Growth(%) | 86.38 | 2.33 | -11.88 | 28.23 | - |
| EPS Growth(%) | 86.38 | 2.33 | -11.88 | -99.27 | - |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | 0.15 |
| Current Ratio(x) | 2.50 | 2.38 | 2.54 | 2.44 | 2.03 |
| Quick Ratio(x) | 1.97 | 2.02 | 2.15 | 2.04 | 1.50 |
| Interest Cover(x) | 4,144.87 | 1,368.05 | 160.39 | 74.71 | 36.89 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of BLUE JET HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BLUE JET HEALTHCARE | ₹11,763.3 Cr | -5% | -12.7% | 29.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,555.0 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
| CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics | |
BLUE JET HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BLUE JET HEALTHCARE | -5% |
-12.7% |
29.7% |
| SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses
